Delivery Order SPE2DB20D2014-SPE2DB25FB62C
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,375.35 firm fixed-price delivery order is for Lantus SoloStar 100 unit/mL 3mL, a medication used to treat diabetes. The contract has an ultimate completion date of April 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,087.68 firm fixed price delivery order is for the supply of Lantus SoloStar 100 unit/mL 3mL, a medication used to treat diabetes. The contract has an ultimate completion date of November 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.80 firm fixed-price delivery order is for the supply of Lantus SoloStar 100 unit/mL 3mL, a medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,384.50, is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a medical product used for the treatment of diabetes. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 25, 2025. This award is not designated as a set-aside contract....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a specialty medication used to manage diabetes. The contract has a firm fixed price of $2,136.24 and a period of performance through May 3, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,799.93, is a delivery order for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to manage diabetes. The contract has an ultimate completion date of November 14, 2023 and is a firm fixed-price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $5,345.76 contract is for the delivery of 4566328878 units of Lantus SoloStar 100 unit/mL 3mL, a specialty medication used to treat diabetes. The contract has an ultimate completion date of November 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,748.20, is for the supply of Lantus SoloStar 100 Unit/mL 3mL, a medication used to treat diabetes. The contract has an ultimate completion date of March 3, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,896.39, is for the supply of Lantus SoloStar 100 unit/mL 3mL, a medication used to treat diabetes. The contract has a firm fixed price pricing type and a performance period ending on May 7, 2025. No set-aside designation is mentioned, indicating this was an open competition. AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,694.19 firm fixed-price delivery order contract is for the supply of Lantus SoloStar 100 unit/mL 3mL, a specialty medication used in the treatment of diabetes. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. This award is part of a larger $999,999,999 Indefinite...